Association between serum ferritin levels and risk of the metabolic syndrome in Chinese adults: a population study.

Jiang Li, Rui Wang, Dan Luo, Shuang Li, Cheng Xiao
Author Information
  1. Jiang Li: Department of Laboratory Medicine, China-Japan Friendship Hospital, Ministry of Health, Beijing, China.

Abstract

Ferritin is a ubiquitous intracellular protein that can store and release iron and act as a buffer against iron deficiency and iron overload. Ferritin is widely used as a clinical biomarker to evaluate iron status. Increased serum ferritin concentrations have been reported to be associated with metabolic syndrome (MetS) features. However, serum ferritin concentrations differ significantly according to sex and ethnicity, and the data concerning the relationship between serum ferritin concentrations and MetS in Asian men and women are conflicting. This study aimed to explore the relationship between serum ferritin and MetS in Chinese population. Fasting blood samples and anthropometric data collected on 8,441 adults aged 18 and older in 2009 as part of the China Health and Nutrition Survey, a large-scale longitudinal, household-based survey in China. Data was collected by trained physicians and biomarkers were measured with Hitachi Clinical Autoanalyzer 7600 D model and P model. Median levels of serum ferritin were significantly higher in men compared with women (121.9 vs. 51.0 ng/ml, P < 0.001), and significantly lower in non metabolic syndrome population with MetS population (73.2 vs. 106.0 ng/ml, P < 0.001). The difference remained significant after further adjusted for age, nationality, Body mass index (BMI), smoking status, and alcohol consumption. For both men and women, the highest prevalence of MetS occurred in the highest quartile of serum ferritin. The odds ratios increased progressively across the ferritin quartiles (P<0.001 for trend). Increased serum ferritin concentrations are associated with the metabolic syndrome among men and women in China.

References

  1. N Engl J Med. 1988 Mar 31;318(13):809-14 [PMID: 3281000]
  2. Public Health Nutr. 2009 Apr;12(4):444-54 [PMID: 18498676]
  3. Ann Intern Med. 1998 Dec 1;129(11):925-31 [PMID: 9867744]
  4. Clin Endocrinol (Oxf). 2003 Mar;58(3):380-5 [PMID: 12608945]
  5. Indian J Med Res. 2010 Jul;132:56-61 [PMID: 20693590]
  6. Soc Sci Med. 2009 Apr;68(7):1305-14 [PMID: 19232811]
  7. Arch Intern Med. 2007 Apr 9;167(7):722-6 [PMID: 17420432]
  8. Am Heart J. 2000 Jul;140(1):98-104 [PMID: 10874269]
  9. Int J Epidemiol. 2010 Dec;39(6):1435-40 [PMID: 19887509]
  10. Diabetes Care. 2003 Nov;26(11):3153-9 [PMID: 14578254]
  11. Eur J Haematol. 2001 Feb;66(2):115-25 [PMID: 11168519]
  12. J Adolesc Health. 2010 Apr;46(4):339-45 [PMID: 20307822]
  13. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):e13-8 [PMID: 14766739]
  14. Eur J Clin Nutr. 2006 Jun;60(6):802-9 [PMID: 16493453]
  15. Int J Obes Relat Metab Disord. 2003 Sep;27(9):1093-9 [PMID: 12917716]
  16. J Hypertens. 2002 Aug;20(8):1513-8 [PMID: 12172312]
  17. Diabetes Care. 2008 Feb;31(2):285-6 [PMID: 17909092]
  18. Diabetologia. 1984 Jun;26(6):441-4 [PMID: 6381191]
  19. Intern Med. 2010;49(2):117-24 [PMID: 20075574]
  20. PLoS One. 2012;7(10):e48250 [PMID: 23144745]
  21. Eur J Clin Nutr. 1993 May;47(5):333-46 [PMID: 8319669]
  22. Diabetes Care. 2004 Feb;27(2):622-3 [PMID: 14747258]
  23. Br Med Bull. 1993 Jul;49(3):642-52 [PMID: 8221029]
  24. Diabetes Care. 2005 Aug;28(8):2061-3 [PMID: 16043762]
  25. Diabetes Care. 2006 Aug;29(8):1878-83 [PMID: 16873796]
  26. J Clin Endocrinol Metab. 2008 Dec;93(12):4690-6 [PMID: 18796516]
  27. J Clin Endocrinol Metab. 1993 Aug;77(2):478-83 [PMID: 8345055]
  28. Int J Obes Relat Metab Disord. 2001 May;25(5):639-45 [PMID: 11360145]
  29. Metabolism. 2005 Nov;54(11):1510-4 [PMID: 16253641]
  30. JAMA. 2004 Feb 11;291(6):711-7 [PMID: 14871914]
  31. Eur J Pediatr. 2003 Mar;162(3):139-146 [PMID: 12655415]
  32. Diabetes Care. 1997 Mar;20(3):426-8 [PMID: 9051399]
  33. Atherosclerosis. 2002 Nov;165(1):179-84 [PMID: 12208485]
  34. Eur J Clin Invest. 1973 May;3(3):179-87 [PMID: 4724685]
  35. Diabetes Care. 2004 Oct;27(10):2422-8 [PMID: 15451911]
  36. Diabetes Care. 2012 Dec;35(12):2521-6 [PMID: 22933431]
  37. PLoS One. 2012;7(6):e39234 [PMID: 22737230]
  38. Metabolism. 2011 Mar;60(3):414-20 [PMID: 20423745]
  39. Atherosclerosis. 1997 Feb 10;128(2):235-40 [PMID: 9050780]

Grants

  1. R01-HD38700/NICHD NIH HHS
  2. R01 HD038700/NICHD NIH HHS
  3. R01 HD030880/NICHD NIH HHS
  4. R21 DK089306/NIDDK NIH HHS
  5. R21DK089306/NIDDK NIH HHS
  6. P30 DK056350/NIDDK NIH HHS
  7. DK056350/NIDDK NIH HHS
  8. R24 HD050924/NICHD NIH HHS
  9. R01-HD30880/NICHD NIH HHS

MeSH Term

Adolescent
Adult
Aged
Aged, 80 and over
Body Mass Index
China
Female
Ferritins
Humans
Male
Metabolic Syndrome
Middle Aged
Young Adult

Chemicals

Ferritins

Word Cloud

Created with Highcharts 10.0.0ferritinserumMetSironconcentrationsmetabolicsyndromemenwomenpopulation0significantlyChinaP001FerritinstatusIncreasedassociateddatarelationshipstudyChinesecollectedmodellevelsvsng/ml<highestubiquitousintracellularproteincanstorereleaseactbufferdeficiencyoverloadwidelyusedclinicalbiomarkerevaluatereportedfeaturesHoweverdifferaccordingsexethnicityconcerningAsianconflictingaimedexploreFastingbloodsamplesanthropometric8441adultsaged18older2009partHealthNutritionSurveylarge-scalelongitudinalhousehold-basedsurveyDatatrainedphysiciansbiomarkersmeasuredHitachiClinicalAutoanalyzer7600DMedianhighercompared121951lowernon732106differenceremainedsignificantadjustedagenationalityBodymassindexBMIsmokingalcoholconsumptionprevalenceoccurredquartileoddsratiosincreasedprogressivelyacrossquartilesP<0trendamongAssociationriskadults:

Similar Articles

Cited By